J&J Signals Optimism With Covid Vaccine Use in Limbo in U.S. (4)

April 20, 2021, 3:26 PM

Johnson & Johnson indicated that uncertainty regarding its Covid-19 vaccine could ease in coming days, as regulators review whether the shot can cause rare blood clots and inspect a factory that’s key to the drugmaker hitting its production targets.

The U.S. paused use of the vaccine last week after six women who received it developed serious but rare blood clots in the brain. A panel of medical experts reviewing data on the clots could vote Friday on whether the hold should end. No additional cases of the clots have been confirmed since the pause began, according to Jason McDonald, a ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.